Celularity (CELU) Intangibles (2020 - 2025)
Celularity (CELU) posted quarterly Intangibles of $7.8 million for Q4 2025, up 1008.0% year-over-year from $700000.0 in Q4 2024, and up 1008.0% quarter-over-quarter from $700000.0 in Q3 2025.
Celularity (CELU) Intangibles (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Intangibles for 6 consecutive years, with $7.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Intangibles rose 1008.0% year-over-year to $7.8 million; the TTM figure through Dec 2025 stood at $7.8 million (up 1008.0% YoY), while the FY2025 annual figure was $7.8 million, up 1008.0% from the prior year.
- Intangibles grew to $7.8 million in Q4 2025 per CELU's latest filing, from $700000.0 in the prior quarter.
- Across five years, Intangibles topped out at $123.7 million in Q3 2021 and bottomed at $700000.0 in Q4 2024.
- Historically, Intangibles has averaged $27.9 million across 5 years, with a median of $11.3 million in 2023.
- Annual changes were most pronounced in 2024 — Intangibles sank 93.64% — and 2025, when it surged 1008.0%.
- Celularity's Intangibles stood at $123.2 million in 2021, then tumbled by 89.86% to $12.5 million in 2022, then slipped by 11.95% to $11.0 million in 2023, then tumbled by 93.64% to $700000.0 in 2024, then soared by 1008.0% to $7.8 million in 2025.
- Business Quant data shows CELU's Intangibles at $7.8 million in Q4 2025, $700000.0 in Q3 2025, and $700000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Celularity | 21.36 Mn | 15.19 Mn | -3.27 Mn | 23.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.76 Mn |
| Sep 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 8.88 Mn |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 8.92 Mn |
| Jun 30, 2024 | 9.30 Mn |
| Mar 31, 2024 | 9.76 Mn |
| Dec 31, 2023 | 11.00 Mn |
| Sep 30, 2023 | 11.55 Mn |
| Jun 30, 2023 | 12.11 Mn |
| Mar 31, 2023 | 120.45 Mn |
| Dec 31, 2022 | 12.49 Mn |
| Sep 30, 2022 | 13.05 Mn |
| Jun 30, 2022 | 13.60 Mn |
| Mar 31, 2022 | 14.15 Mn |
| Dec 31, 2021 | 123.19 Mn |
| Sep 30, 2021 | 123.74 Mn |
| Dec 31, 2020 | 125.38 Mn |